• 1851 Citations
  • 25 h-Index
1991 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Luis A. Herrera is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Neoplasms Medicine & Life Sciences
Lymphocytes Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Mexico Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

Airborne particulate matter induces mitotic slippage and chromosomal missegregation through disruption of the spindle assembly checkpoint (SAC)

Santibáñez-Andrade, M., Sánchez-Pérez, Y., Chirino, Y. I., Morales-Bárcenas, R., Herrera, L. A. & Garcia-Cuellar, C., Nov 1 2019, In : Chemosphere. 235, p. 794-804 11 p.

Research output: Contribution to journalArticle

M Phase Cell Cycle Checkpoints
Particulate Matter
particulate matter
protein
Proteins

Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients

Fragoso-Ontiveros, V., Velázquez-Aragón, J. A., Nuñez-Martínez, P. M., de la Luz Mejía-Aguayo, M., Vidal-Millán, S., Pedroza-Torres, A., Sánchez-Contreras, Y., Ramírez-Otero, M. A., Muñiz-Mendoza, R., Domínguez-Ortíz, J., Wegman-Ostrosky, T., Bargalló-Rocha, J. E., Gallardo-Rincón, D., Reynoso-Noveron, N., Arriaga-Canon, C., Meneses-García, A., Herrera-Montalvo, L. A. & Alvarez-Gomez, R. M., Jan 1 2019, In : PloS one. 14, 9, e0222709.

Research output: Contribution to journalArticle

Open Access
ovarian neoplasms
Polymerase chain reaction
Target tracking
shortenings
breast neoplasms

MiRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments

Martinez-Gutierrez, A. D., Catalan, O. M., Vázquez-Romo, R., Reyes, F. I. P., Alvarado-Miranda, A., Medina, F. L., Bargallo-Rocha, J. E., Moreno, L. T. O., de León, D. C., Herrera, L. A., López-Camarillo, C., Pérez-Plasencia, C. & Campos-Parra, A. D., Jan 1 2019, In : International journal of molecular medicine. 44, 4, p. 1267-1280 14 p.

Research output: Contribution to journalArticle

Open Access
MicroRNAs
Breast Neoplasms
Biomarkers
Therapeutics
Disease-Free Survival

Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population

Gallardo-Alvarado, L. N., Tusié-Luna, M. T., Tussié-Luna, M. I., Diaz-Chavez, J., Segura, Y. X., Bargallo-Rocha, E., Villarreal, C., Herrera, L. A., Herrera-Medina, E. M. & Cantu-De Leon, D. F., Feb 1 2019, In : BMC cancer. 19, 1, 118.

Research output: Contribution to journalArticle

Germ-Line Mutation
p53 Genes
Breast Neoplasms
Mutation
Li-Fraumeni Syndrome

Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016

Ylescas-Soria, J., de la Torre-Lujan, A. H., Herrera, L. A., Miranda, D., Grimaldo, F., Rivas, S., Cervera, E., Meneses-García, A., Leon-Sarmiento, F. E. & Prada, D. G., Jun 1 2019, In : Cancer medicine. 8, 6, p. 2942-2949 8 p.

Research output: Contribution to journalArticle

Open Access
National Cancer Institute (U.S.)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Mexico
Survival
Confidence Intervals